| Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial RS Bresalier, RS Sandler, H Quan, JA Bolognese, B Oxenius, K Horgan, ... New England Journal of Medicine 352 (11), 1092-1102, 2005 | 3305 | 2005 |
| Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial WS Atkin, R Edwards, I Kralj-Hans, K Wooldrage, AR Hart, JMA Northover, ... The Lancet 375 (9726), 1624-1633, 2010 | 2097 | 2010 |
| Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ... The Lancet 396 (10243), 27-38, 2020 | 1865 | 2020 |
| Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1541 | 2020 |
| Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’study HJN Andreyev, AR Norman, D Cunningham, J Oates, BR Dix, ... British journal of cancer 85 (5), 692-696, 2001 | 1103 | 2001 |
| Global guidance for surgical care during the COVID-19 pandemic Journal of British Surgery 107 (9), 1097-1103, 2020 | 687 | 2020 |
| A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas JA Baron, RS Sandler, RS Bresalier, H Quan, R Riddell, A Lanas, ... Gastroenterology 131 (6), 1674-1682, 2006 | 564 | 2006 |
| Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial Foxtrot Collaborative Group The lancet oncology 13 (11), 1152-1160, 2012 | 509 | 2012 |
| Global burden of postoperative death D Nepogodiev, J Martin, B Biccard, A Makupe, A Bhangu, A Ademuyiwa, ... The Lancet 393 (10170), 401, 2019 | 473 | 2019 |
| Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study A Bhangu, AO Ademuyiwa, ML Aguilera, P Alexander, SW Al-Saqqa, ... The Lancet Infectious Diseases 18 (5), 516-525, 2018 | 441 | 2018 |
| The Wnt antagonist sFRP1 in colorectal tumorigenesis GM Caldwell, C Jones, K Gensberg, S Jan, RG Hardy, P Byrd, S Chughtai, ... Cancer research 64 (3), 883-888, 2004 | 374 | 2004 |
| Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial W Atkin, E Dadswell, K Wooldrage, I Kralj-Hans, C von Wagner, ... The Lancet 381 (9873), 1194-1202, 2013 | 308 | 2013 |
| Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial) TD Pinkney, M Calvert, DC Bartlett, A Gheorghe, V Redman, G Dowswell, ... Bmj 347, 2013 | 302 | 2013 |
| Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial JA Baron, RS Sandler, RS Bresalier, A Lanas, DG Morton, R Riddell, ... The Lancet 372 (9651), 1756-1764, 2008 | 300 | 2008 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 258 | 2021 |
| Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer … YL Wallis, DG Morton, CM McKeown, F Macdonald Journal of Medical Genetics 36 (1), 14-20, 1999 | 237 | 1999 |
| The outcome of surgery in fulminant Clostridium difficile colitis K Koss, MA Clark, DSA Sanders, D Morton, MRB Keighley, J Goh Colorectal disease 8 (2), 149-154, 2006 | 220 | 2006 |
| Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial S Halligan, K Wooldrage, E Dadswell, I Kralj-Hans, C Von Wagner, ... The Lancet 381 (9873), 1185-1193, 2013 | 213 | 2013 |
| Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis SMA Phillips, CM Barton, SJ Lee, DG Morton, DMA Wallace, NR Lemoine, ... British journal of cancer 70 (6), 1252-1257, 1994 | 193 | 1994 |
| FOxTROT: an international randomised controlled trial in 1052 patients (pts) evaluating neoadjuvant chemotherapy (NAC) for colon cancer. MT Seymour, D Morton, International FOxTROT Trial Investigators Journal of Clinical Oncology 37 (15_suppl), 3504-3504, 2019 | 192 | 2019 |
